Bisseye, C <br/><br/>
An engineered Plasmodium falciparum C-terminal 19-kilodalton merozoite surface protein 1 vaccine candidate induces high levels of interferon-gamma production associated with cellular immune responses to specific peptide sequences in Gambian adults naturally exposed to malaria.  [electronic resource] 

 -  Clinical and experimental immunology  Dec 2011 
 - 366-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2249 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2249.2011.04467.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Protozoan--immunology<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cytokines--biosynthesis<br/>Gambia<br/>HLA-DR Antigens--analysis<br/>Humans<br/>Interferon-gamma--biosynthesis<br/>Interleukin-13--biosynthesis<br/>Ki-1 Antigen--biosynthesis<br/>Malaria Vaccines--immunology<br/>Malaria, Falciparum--immunology<br/>Merozoite Surface Protein 1--genetics<br/>Plasmodium falciparum--cytology<br/>Protozoan Proteins--immunology<br/>Recombinant Proteins--genetics<br/>Th1 Cells--immunology<br/>Th1-Th2 Balance<br/>Th2 Cells--immunology<br/>Vaccines, Synthetic--immunology